Koers Beleave Inc. Canadian Securities Exchange
Aandelen
BE
CA0775611084
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | 2,37 3,25 2,18 | Marktkapitalisatie | 30,37 mln. 41,56 mln. 27,86 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -12 mln. -16,42 mln. -11,01 mln. | Nettowinst (verlies) 2019 | -33 mln. -45,15 mln. -30,27 mln. | EV/omzet 2018 | - |
Nettoliquiditeiten 2018 | 5,2 mln. 7,12 mln. 4,77 mln. | Nettoschuld 2019 | 10,32 mln. 14,12 mln. 9,46 mln. | EV/omzet 2019 | 17.137.012 x |
K/w-verhouding 2018 |
-4,72
x | K/w-verhouding 2019 |
-0,76
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 98,39% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 26-05-00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-15 |
Founder | - | 26-05-00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24-10-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,94% | 4,81 mld. | |
-32,21% | 3,6 mld. | |
-1,43% | 3,09 mld. | |
-25,09% | 2,62 mld. | |
-11,46% | 2,27 mld. | |
+36,65% | 1,82 mld. | |
+37,15% | 1,41 mld. | |
-16,01% | 1,38 mld. | |
+40,95% | 1,37 mld. |